Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Greinix, Hildegard  [Clear All Filters]
2022
Perovic V, Sabol I, Grce M, Inngjerdingen M, Pulanic D, Peric Z, Peczynski C, Polge E, Koenecke C, Dickinson A, et al. Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network. Bone Marrow Transplant. 2022.
Alseraihy A, McGrath E, Niederwieser D, Chabannon C, Szer J, Mohty M, Kharfan-Dabaja MA, Orchard K, Schwartz J, Rasheed W, et al. WBMT Special Article on Key Elements in Quality and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy. Transplant Cell Ther. 2022.
2021
Scheidl S, Avian A, Flick H, Gaal S, Greinix H, Olschewski H. Impact of smoking behavior on survival following allogeneic hematopoietic stem cell transplantation - smoking cessation matters. Nicotine Tob Res. 2021.
Pidala J, Kitko C, Lee SJ, Carpenter P, Cuvelier GDE, Holtan S, Flowers MED, Cutler C, Jagasia M, Gooley T, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report. Transplant Cell Ther. 2021.
2020
Robak O, Kastner M-T, Stecher C, Schneider M, Andreas M, Greinix H, Kallay E, Honsig C, Steininger C. Cytomegalovirus Infection Downregulates Vitamin-D Receptor in Patients Undergoing Hematopoietic Stem Cell Transplantation. Transplantation. 2020.
Penack O, Marchetti M, Ruutu T, Aljurf M, Bacigalupo A, Bonifazi F, Ciceri F, Cornelissen J, Malladi R, Duarte RF, et al. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. Lancet Haematol. 2020;7(2):e157-e167.
Algwaiz G, Aljurf M, Koh M, Horowitz MM, Ljungman P, Weisdorf D, Saber W, Kodera Y, Szer J, Jawdat D, et al. Real-world issues and potential solutions in HCT during the COVID-19 pandemic: Perspectives from the WBMT and the CIBMTR's Health Services and International Studies Committee. Biol Blood Marrow Transplant. 2020.
2019
Pasquini MC, Srivastava A, Ahmed SOsman, Aljurf M, Atsuta Y, Doleysh C, Galeano S, Gluckman E, Greinix H, Hale G, et al. Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): Minimum requirements and beyond. Hematol Oncol Stem Cell Ther. 2019.
2018
Inamoto Y, Valdés-Sanz N, Ogawa Y, Alves M, Berchicci L, Galvin J, Greinix H, Hale GA, Horn B, Kelly D, et al. Ocular graft-versus-host disease after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Biol Blood Marrow Transplant. 2018.
Scheidl S, Zinke-Cerwenka W, Flick H, Gaal S, Avian A, Greinix H, Olschewski H. Whole body lung function test-derived outcome predictors in allogenic stem cell transplantation. Biol Blood Marrow Transplant. 2018.
2016
Schwarz C, Lawitschka A, Böhmig GA, Dauber EM, Greinix H, Kozakowski N, Mühlbacher F, Berlakovich GA, Wekerle T. Kidney Transplantation With Corticosteroids Alone After Haploidentical HSCT From The Same Donor. Transplantation. 2016.
2014
Brüggen M-C, Petzelbauer P, Greinix H, Contassot E, Jankovic D, French L, Socié G, Rabitsch W, Kuzmina Z, Kalhs P, et al. Epidermal Elafin Expression is an Indicator of Poor Prognosis in Cutaneous Graft-versus-Host Disease. J Invest Dermatol. 2014.
2013
Brüggen M-C, Klein I, Greinix H, Bauer W, Kuzmina Z, Rabitsch W, Kalhs P, Petzelbauer P, Knobler R, Stingl G, et al. Diverse T cell responses characterize the different manifestations of cutaneous graft-versus-host disease. Blood. 2013.